Cite
HARVARD Citation
D'Angelo, S. et al. (2021). First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study. Journal for immunotherapy of cancer. 9 (7), p. . [Online].